IL6 and nonpapillary renal cell carcinoma: We speculate that this phenomenon occurs not only because CRP enhances the expression of PD‐L1 in TAMs but also because it contributes to the production of IL‐6 in TAMs and the activation of STAT3 in tumor tissues, thereby accelerating the proliferation of ccRCC tumor cells and reducing the effectiveness of ICI treatment.